A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application
Clinical trial NCT02980315 · UNKNOWN
Trial details
- NCT number
- NCT02980315
- Sponsor
- The Second Hospital of Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2017-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.